Kaftan, O. Et Al. 2011. Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients. MEDICAL PRINCIPLES AND PRACTICE , vol.20, no.4 , 332-335.

Kaftan, O., KASAPOĞLU, B., Koroglu, M., KOŞAR, A., & Yalcin, S., (2011). Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients. MEDICAL PRINCIPLES AND PRACTICE , vol.20, no.4, 332-335.

Kaftan, O. Et Al. "Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients," MEDICAL PRINCIPLES AND PRACTICE , vol.20, no.4, 332-335, 2011

Kaftan, O. Et Al. "Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients." MEDICAL PRINCIPLES AND PRACTICE , vol.20, no.4, pp.332-335, 2011

Kaftan, O. Et Al. (2011) . "Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients." MEDICAL PRINCIPLES AND PRACTICE , vol.20, no.4, pp.332-335.

@article{article, author={O. Kaftan Et Al. }, title={Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients}, journal={MEDICAL PRINCIPLES AND PRACTICE}, year=2011, pages={332-335} }